Adler, M.; Pellett, S.; Sharma, S.K.; Lebeda, F.J.; Dembek, Z.F.; Mahan, M.A.
Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury. Microorganisms 2022, 10, 886.
https://doi.org/10.3390/microorganisms10050886
AMA Style
Adler M, Pellett S, Sharma SK, Lebeda FJ, Dembek ZF, Mahan MA.
Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury. Microorganisms. 2022; 10(5):886.
https://doi.org/10.3390/microorganisms10050886
Chicago/Turabian Style
Adler, Michael, Sabine Pellett, Shashi K. Sharma, Frank J. Lebeda, Zygmunt F. Dembek, and Mark A. Mahan.
2022. "Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury" Microorganisms 10, no. 5: 886.
https://doi.org/10.3390/microorganisms10050886
APA Style
Adler, M., Pellett, S., Sharma, S. K., Lebeda, F. J., Dembek, Z. F., & Mahan, M. A.
(2022). Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury. Microorganisms, 10(5), 886.
https://doi.org/10.3390/microorganisms10050886